ANIP 55.00 ANI Pharmaceuticals Inc $ANIP Hit a 52
Post# of 84
Posted On: 11/17/2014 10:09:25 AM
ANIP 55.00 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high of 55.35 Closing the day 09:44 at 55.00 +1.05 +1.95% With a day low of 54.01 and a total volume of 45,608.
ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/
ANIP ANI Pharmaceuticals Inc Recent Headline News
Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 23 mins ago
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 55.62 (+1.67), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24), PBYI: 219.00 (+2.78)
Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 305.86 (+0.43), ANIP: 55.62 (+1.67), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24)
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 55.62 (+1.67), ICPT: 159.01 (-3.57), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24)
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 55.62 (+1.67)
ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 55.62 (+1.67), SCMP: 11.60 (+0.30)
Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 55.62 (+1.67)
Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 305.86 (+0.43), ANIP: 55.62 (+1.67), CLDX: 17.27 (+3.11), AMAG: 34.86 (+0.86)
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.59 (+0.13), ANIP: 55.62 (+1.67), ACGL: 56.87 (-0.43), ACCO: 8.96 (-0.03), FLWS: 8.98 (-0.01)
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 55.62 (+1.67)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.53 (-0.45), HBNK: 20.10 (+0.32), ASMI: 41.46 (+0.20), RRGB: 68.08 (-0.43), SAPE: 24.69 (+0.01), PLUG: 3.78 (+0.06), ANIP: 55.62 (+1.67), ODP: 6.57 (-0.22), MTEX: 21.41 (+1.10), JAXB: 11.75 (-0.15), ALQA: 5.07 (+0.02), YRCW: 23.96 (+0.23)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 6.14 (+0.06), NEO: 4.66 (-0.02), AU: 9.33 (-0.23), FNHC: 24.82 (+0.09), AMS: 2.53 (-0.19), NYMX: 0.58 (+0.03), AMDA: 1.39 (+0.17), CVD: 100.36 (+0.06), GBIM: 6.50 (+0.20), RCAP: 12.00 (-0.09), KBIO: 2.02 (-0.08), COOL: 0.85 (-0.05), SAPE: 24.69 (+0.01), XTLB: 2.58 (+0.13), GERN: 2.93 (+0.17), ANIP: 55.62 (+1.67), BBLU: 1.26 (-0.04), NXTD: 2.29 (-0.02), AP: 18.80 (-0.08), ALQA: 5.07 (+0.02)
ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST
ANIP: 55.62 (+1.67)
ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 55.62 (+1.67)
ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST
ANIP: 55.62 (+1.67)
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI" (NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014.
ANIP: 55.62 (+1.67)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST
ACW: 4.74 (-0.07), SYY: 38.78 (+0.20), L: 42.52 (-0.26), EEP: 37.56 (+0.22), SNH: 22.24 (+0.06), INN: 11.52 (-0.02), ITG: 19.70 (+0.19), NSP: 33.00 (+0.02), S: 5.03 (-0.02), ALE: 49.93 (+0.10), GVA: 36.44 (+0.17), MCY: 53.95 (-0.10), ARNA: 4.58 (+0.05), CHD: 73.44 (-0.09), ARE: 82.62 (+0.30), USAK: 18.44 (-0.01), BWP: 16.83 (-0.12), KRG: 26.17 (-0.03), CYOU: 23.50 (-0.37), MNKD: 6.08 (-0.08), HNT: 50.55 (+0.75), AMH: 17.24 (-0.03), ARCB: 42.78 (+0.17), ANIP: 55.62 (+1.67), AMG: 195.42 (-1.52), HAE: 37.12 (-0.01), SOHU: 50.14 (-0.82), CNA: 38.99 (-0.13)
ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 107.70 (+0.80), MACK: 8.63 (+0.15), ANIP: 55.62 (+1.67), ILMN: 180.99 (+0.49)
ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT
ANIP: 55.62 (+1.67)
5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 55.62 (+1.67), KTOS: 5.38 (-0.02), BLOX: 17.06 (+0.20), CSLT: 11.42 (-0.44), FPRX: 15.28 (+0.09)
ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/
ANIP ANI Pharmaceuticals Inc Recent Headline News
Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 23 mins ago
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 55.62 (+1.67), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24), PBYI: 219.00 (+2.78)
Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 305.86 (+0.43), ANIP: 55.62 (+1.67), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24)
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 55.62 (+1.67), ICPT: 159.01 (-3.57), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24)
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 55.62 (+1.67)
ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 55.62 (+1.67), SCMP: 11.60 (+0.30)
Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 55.62 (+1.67)
Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 305.86 (+0.43), ANIP: 55.62 (+1.67), CLDX: 17.27 (+3.11), AMAG: 34.86 (+0.86)
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.59 (+0.13), ANIP: 55.62 (+1.67), ACGL: 56.87 (-0.43), ACCO: 8.96 (-0.03), FLWS: 8.98 (-0.01)
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health. ANIP: 55.62 (+1.67)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.53 (-0.45), HBNK: 20.10 (+0.32), ASMI: 41.46 (+0.20), RRGB: 68.08 (-0.43), SAPE: 24.69 (+0.01), PLUG: 3.78 (+0.06), ANIP: 55.62 (+1.67), ODP: 6.57 (-0.22), MTEX: 21.41 (+1.10), JAXB: 11.75 (-0.15), ALQA: 5.07 (+0.02), YRCW: 23.96 (+0.23)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 6.14 (+0.06), NEO: 4.66 (-0.02), AU: 9.33 (-0.23), FNHC: 24.82 (+0.09), AMS: 2.53 (-0.19), NYMX: 0.58 (+0.03), AMDA: 1.39 (+0.17), CVD: 100.36 (+0.06), GBIM: 6.50 (+0.20), RCAP: 12.00 (-0.09), KBIO: 2.02 (-0.08), COOL: 0.85 (-0.05), SAPE: 24.69 (+0.01), XTLB: 2.58 (+0.13), GERN: 2.93 (+0.17), ANIP: 55.62 (+1.67), BBLU: 1.26 (-0.04), NXTD: 2.29 (-0.02), AP: 18.80 (-0.08), ALQA: 5.07 (+0.02)
ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST
ANIP: 55.62 (+1.67)
ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 55.62 (+1.67)
ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST
ANIP: 55.62 (+1.67)
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014. ANIP: 55.62 (+1.67)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST
ACW: 4.74 (-0.07), SYY: 38.78 (+0.20), L: 42.52 (-0.26), EEP: 37.56 (+0.22), SNH: 22.24 (+0.06), INN: 11.52 (-0.02), ITG: 19.70 (+0.19), NSP: 33.00 (+0.02), S: 5.03 (-0.02), ALE: 49.93 (+0.10), GVA: 36.44 (+0.17), MCY: 53.95 (-0.10), ARNA: 4.58 (+0.05), CHD: 73.44 (-0.09), ARE: 82.62 (+0.30), USAK: 18.44 (-0.01), BWP: 16.83 (-0.12), KRG: 26.17 (-0.03), CYOU: 23.50 (-0.37), MNKD: 6.08 (-0.08), HNT: 50.55 (+0.75), AMH: 17.24 (-0.03), ARCB: 42.78 (+0.17), ANIP: 55.62 (+1.67), AMG: 195.42 (-1.52), HAE: 37.12 (-0.01), SOHU: 50.14 (-0.82), CNA: 38.99 (-0.13)
ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 107.70 (+0.80), MACK: 8.63 (+0.15), ANIP: 55.62 (+1.67), ILMN: 180.99 (+0.49)
ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT
ANIP: 55.62 (+1.67)
5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 55.62 (+1.67), KTOS: 5.38 (-0.02), BLOX: 17.06 (+0.20), CSLT: 11.42 (-0.44), FPRX: 15.28 (+0.09)
(0)
(0)ANI Pharmaceuticals Inc. (ANIP) Stock Research Links
Scroll down for more posts ▼